Literature DB >> 3678467

Composition of proteoglycans from human atherosclerotic lesions.

E R Dalferes1, B Radhakrishnamurthy, H A Ruiz, G S Berenson.   

Abstract

Proteoglycans from human atherosclerotic lesions and from uninvolved aortic intima were isolated and their composition was studied. The tissues were sequentially extracted by guanidine hydrochloride followed by hydrolysis of the tissue by elastase. Chondroitin sulfate/dermatan sulfate proteoglycans were predominant in guanidine hydrochloride extracts of the tissue. Most of the heparan sulfate proteoglycans were released from the tissue by hydrolysis with elastase. The content of proteoglycan material, measured as uronate per unit weight of wet tissue, was lower in fatty streaks and fibrous plaques than in uninvolved tissue (0.58 and 0.48 mg vs. 0.7 mg/g wet tissue). The distribution of different glycosaminoglycans in guanidine hydrochloride-extracted proteoglycans was similar among the lesions and uninvolved tissue, but varied in the elastase-hydrolyzed extracts. Gel filtration studies suggested that the major proteoglycan material, chondroitin sulfate proteoglycans, from lesions had greater molecular weight than proteoglycans from uninvolved tissue. The studies indicate that alteration in intrinsic composition and molecular size of proteoglycans occurs in atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678467     DOI: 10.1016/0014-4800(87)90019-0

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta.

Authors:  R Kruse; M Merten; K Yoshida; A Schmidt; W Völker; E Buddecke
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

2.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin.

Authors:  G Fager; G Camejo; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

3.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. II. The platelet-derived growth factor A-chain contains a sequence that specifically binds heparin.

Authors:  G Fager; G Camejo; U Olsson; G Ostergren-Lundén; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

4.  Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus.

Authors:  F Wasty; M Z Alavi; S Moore
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

5.  Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells.

Authors:  E Papakonstantinou; G Karakiulakis; M Roth; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

6.  Macrophages bind LDL using heparan sulfate and the perlecan protein core.

Authors:  Chun-Yi Ng; John M Whitelock; Helen Williams; Ha Na Kim; Heather J Medbury; Megan S Lord
Journal:  J Biol Chem       Date:  2021-03-05       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.